These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12946297)

  • 1. Cost-effectiveness of serotesting compared with universal immunization for varicella in refugee children from six geographic regions.
    Figueira M; Christiansen D; Barnett ED
    J Travel Med; 2003; 10(4):203-7. PubMed ID: 12946297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of varicella history with presence of varicella antibody in refugees.
    Christiansen D; Barnett ED
    Vaccine; 2004 Oct; 22(31-32):4233-7. PubMed ID: 15474713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella serology among school age children with a negative or uncertain history of chickenpox.
    Lieu TA; Black SB; Takahashi H; Ray P; Capra AM; Shinefield HR; Adler NE
    Pediatr Infect Dis J; 1998 Feb; 17(2):120-5. PubMed ID: 9493807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of serologic testing for varicella in an adolescent population.
    Ronan K; Wallace MR
    Vaccine; 2001 Sep; 19(32):4700-2. PubMed ID: 11535319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age.
    Kavaliotis J; Petridou S; Karabaxoglou D
    Int J Infect Dis; 2003 Dec; 7(4):274-7. PubMed ID: 14656418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotesting versus presumptive varicella vaccination of adolescents with a negative or uncertain history of chickenpox.
    Harel Z; Ipp L; Riggs S; Vaz R; Flanagan P
    J Adolesc Health; 2001 Jan; 28(1):26-9. PubMed ID: 11137902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of sero-epidemiological characteristics of varicella in healthy children in Jiangsu Province, China.
    Zhang L; Ma W; Liu Y; Wang Y; Sun X; Hu Y; Deng X; Lu P; Tang F; Wang Z; Zhou M
    BMC Infect Dis; 2018 Nov; 18(1):563. PubMed ID: 30428851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
    Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
    BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents.
    Lieu TA; Finkler LJ; Sorel ME; Black SB; Shinefield HR
    Pediatrics; 1995 May; 95(5):632-8. PubMed ID: 7724297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.
    Koturoglu G; Kurugol Z; Turkoglu E
    Paediatr Perinat Epidemiol; 2011 Jul; 25(4):388-93. PubMed ID: 21649681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of measles, rubella, and varicella in refugees.
    Barnett ED; Christiansen D; Figueira M
    Clin Infect Dis; 2002 Aug; 35(4):403-8. PubMed ID: 12145723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of information on varicella history in preschool children.
    Bricks LF; Pannuti CS; Sato HK; Vico ES; de Faria AM; Souza VV; Sumita LM; Costa Ide C; Baldacci ER
    Clinics (Sao Paulo); 2007 Jun; 62(3):309-14. PubMed ID: 17589672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella epidemiology and cost-effectiveness analysis of universal varicella vaccination program in Taiwan.
    Tseng HF; Tan HF; Chang CK
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1450-8. PubMed ID: 16610647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella seroprevalence among health care workers in Korea: validity of self-reported history and cost-effectiveness of prevaccination screening.
    Kang JH; Park YS; Park SY; Kim SB; Ko KP; Seo YH
    Am J Infect Control; 2014 Aug; 42(8):885-7. PubMed ID: 25087140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiology of varicella and the reliability of a self-reported history of varicella infection in Singapore military recruits.
    Dashraath P; Ong ES; Lee VJ
    Ann Acad Med Singap; 2007 Aug; 36(8):636-41. PubMed ID: 17767333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of routine antenatal varicella screening.
    Glantz JC; Mushlin AI
    Obstet Gynecol; 1998 Apr; 91(4):519-28. PubMed ID: 9540934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
    Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
    Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.